CLINICAL TRIAL SUMMARY

MDACC Study No:2011-0804 (clinicaltrials.gov NCT No: NCT01469247)
Title:Phase I/II study of reirradiation of recurrent or progressive brainstem glioma
Principal Investigator:Anita Mahajan
Treatment Agent:Radiation
Study Status:Open
Study Description:The goal of this clinical research study is to find a safe dose of radiation
that can be given to patients with brainstem glioma who have already received
radiation therapy.

You will receive photon radiation therapy. This type of radiation is similar
to the radiation you have already had. Conformal radiotherapy or intensity
modulated radiotherapy (IMRT) will be used to try to treat the tumor while
affecting as little of the surrounding normal tissue as possible.

Hide details for General InformationGeneral Information

Disease Group:Brain
Phase of Study:Phase I/Phase II
Treatment Agents:Radiation
Treatment Location:Both at MDACC & and Other Sites
Estimated Length of Stay in Houston:
Supported By:N/A
Return Visit:
Home Care:


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Anita Mahajan
Dept:Radiation Oncology
For Clinical Trial Enrollment:713-563-2300
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults